Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FABP4 | P15090 | 7/20 | 0.59 |
| ▸ | AKR1C3 | P42330 | 4/20 | 0.57 |
| ▸ | AKR1C2 | P52895 | 3/20 | 0.57 |
| ▸ | MEN1 | O00255 | 2/20 | 0.57 |
| ▸ | AKR1B10 | O60218 | 2/20 | 0.57 |
| ▸ | LMNA | P02545 | 2/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.57 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.57 |
| ▸ | AKR1B1 | P15121 | 2/20 | 0.57 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.57 |
| ▸ | AKR1C1 | Q04828 | 2/20 | 0.57 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.57 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.57 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.57 |
| ▸ | DHFR | P00374 | 1/20 | 0.57 |
| ▸ | MPO | P05164 | 1/20 | 0.57 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.57 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7573481 | 0.87 | CLCN2 (0.53) | FABP4AKR1C3AKR1C2MEN1AKR1B10 | |
| SCHEMBL355549 | 0.83 | FABP4 (0.80) | FABP4AKR1C3AKR1C2MEN1AKR1B10 | |
| SCHEMBL30320327 | 0.83 | FABP4 (0.80) | FABP4AKR1C3AKR1C2MEN1AKR1B10 | |
| SCHEMBL6269689 | 0.83 | FABP4 (0.59) | FABP4AKR1C3AKR1C2MEN1AKR1B10 | |
| Hydrogen Peroxide SCHEMBL9514730 | 0.81 | ALDH1A1 (0.59) | AKR1C3MEN1LMNACYP1A2CYP3A4 | |
| SCHEMBL29657201 | 0.81 | ALDH1A1 (0.59) | AKR1C3MEN1LMNACYP1A2CYP3A4 | |
| SCHEMBL6142375 | 0.81 | FABP4 (0.84) | FABP4AKR1C3AKR1C2MEN1AKR1B10 | |
| SCHEMBL254364 | 0.81 | ALDH1A1 (0.59) | AKR1C3MEN1LMNACYP1A2CYP3A4 | |
| Benzene SCHEMBL28132022 | 0.81 | ALDH1A1 (0.59) | AKR1C3MEN1LMNACYP1A2CYP3A4 | |
| SCHEMBL9691899 | 0.81 | FABP4 (0.77) | FABP4AKR1C3AKR1C2MEN1AKR1B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7888509-B2 | Chiral 1,8-diarylnaphthalenes, methods of making them, and their use as sensors | GEORGETOWN UNIVERSITY (US) | 2011-02-15 | — | — | US | disclosed |
| US-20090131527-A1 | NOVEL ANTHRANILIC ACID DERIVATIVES AND CHLORIDE CHANNEL BLOCKING AGENT CONTAINING THE SAME | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2009-05-21 | — | — | US | disclosed |
| US-20070276140-A1 | Chiral 1,8-Diarylnaphthalenes, Methods of Making Them, and Their Use as Sensors | GEORGETOWN UNIVERSITY (US) | 2007-11-29 | — | — | US | disclosed |
| WO-2005043124-A2 | CHIRAL 1,8-DIARYLNAPHTHALENES, METHODS OF MAKING THEM, AND THEIR USE AS SENSORS | GEORGETOWN UNIVERSITY (US) | 2005-05-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090131527-A1 | NOVEL ANTHRANILIC ACID DERIVATIVES AND CHLORIDE CHANNEL BLOCKING AGENT CONTAINING THE SAME | CLIC1, ASIC1, CLIC4 | FABP4 1600/4885AKR1C3 787/4885AKR1C2 477/4885 |
| US-20070276140-A1 | Chiral 1,8-Diarylnaphthalenes, Methods of Making Them, and Their Use as Sensors | ALKBH2, ALKBH1, ALG3 | FABP4 3500/4885AKR1C3 447/4885AKR1C2 414/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.